TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
121 hedge funds and large institutions have $136M invested in TCR2 Therapeutics Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 34 increasing their positions, 35 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less capital invested
Capital invested by funds: $270M → $136M (-$134M)
57% less call options, than puts
Call options by funds: $123K | Put options by funds: $288K
Holders
121
Holding in Top 10
2
Calls
$123K
Puts
$288K
Top Buyers
| 1 | +$5.39M | |
| 2 | +$5.28M | |
| 3 | +$3.25M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$2.69M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.07M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$8.9M | |
| 3 | -$5.28M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.66M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.08M |